Leufkens HGM - Search Results

1

Efficacy gap between phase II and subsequent phase III studies in oncology.

Vreman RA, Belitser SV, Mota ATM, Hövels AM, Goettsch WG, Roes KCB, Leufkens HGM, Mantel-Teeuwisse AK. Vreman RA, et al. Among authors: leufkens hgm. Br J Clin Pharmacol. 2020 Jul;86(7):1306-1313. doi: 10.1111/bcp.14237. Epub 2020 Feb 21. Br J Clin Pharmacol. 2020. PMID: 32034790 Free PMC article. Clinical Trial.

2

Prescribing patterns in patients using new antidepressants.

Meijer WE, Heerdink ER, Pepplinkhuizen LP, van Eijk JT, Leufkens HG. Meijer WE, et al. Br J Clin Pharmacol. 2001 Feb;51(2):181-3. doi: 10.1111/j.1365-2125.2001.01329.x. Br J Clin Pharmacol. 2001. PMID: 11259993 Free PMC article.

3

Selective serotonin reuptake inhibitor-induced urinary incontinence.

Movig KL, Leufkens HG, Belitser SV, Lenderink AW, Egberts AC. Movig KL, et al. Pharmacoepidemiol Drug Saf. 2002 Jun;11(4):271-9. doi: 10.1002/pds.705. Pharmacoepidemiol Drug Saf. 2002. PMID: 12138594

4

Predicting cardiac arrhythmias and sudden death in diabetic users of proarrhythmic drugs.

De Bruin ML, van Staa TP, Belitser SV, Leufkens HG, Hoes AW. De Bruin ML, et al. Diabetes Care. 2005 Feb;28(2):440-2. doi: 10.2337/diacare.28.2.440. Diabetes Care. 2005. PMID: 15677812 No abstract available.

5

Prior outpatient antibacterial therapy as prognostic factor for mortality in hospitalized pneumonia patients.

van de Garde EM, Souverein PC, van den Bosch JM, Deneer VH, Goettsch WG, Leufkens HG. van de Garde EM, et al. Respir Med. 2006 Aug;100(8):1342-8. doi: 10.1016/j.rmed.2005.11.024. Epub 2006 Jan 18. Respir Med. 2006. PMID: 16412625 Free article.

6

In-hospital cardiac arrest is associated with use of non-antiarrhythmic QTc-prolonging drugs.

De Bruin ML, Langendijk PN, Koopmans RP, Wilde AA, Leufkens HG, Hoes AW. De Bruin ML, et al. Br J Clin Pharmacol. 2007 Feb;63(2):216-23. doi: 10.1111/j.1365-2125.2006.02722.x. Epub 2006 Jul 21. Br J Clin Pharmacol. 2007. PMID: 16869820 Free PMC article.

7

Availability of comparative trials for the assessment of new medicines in the European Union at the moment of market authorization.

van Luijn JC, Gribnau FW, Leufkens HG. van Luijn JC, et al. Br J Clin Pharmacol. 2007 Feb;63(2):159-62. doi: 10.1111/j.1365-2125.2006.02812.x. Epub 2006 Dec 7. Br J Clin Pharmacol. 2007. PMID: 17166187 Free PMC article.

8

Distinguishing patterns in the dynamics of long-term medication use by Markov analysis: beyond persistence.

Menckeberg TT, Belitser SV, Bouvy ML, Bracke M, Lammers JW, Raaijmakers JA, Leufkens HG. Menckeberg TT, et al. BMC Health Serv Res. 2007 Jul 10;7:106. doi: 10.1186/1472-6963-7-106. BMC Health Serv Res. 2007. PMID: 17620145 Free PMC article.

9

Use of beta2 agonists and risk of acute myocardial infarction in patients with hypertension.

de Vries F, Pouwels S, Bracke M, Lammers JW, Klungel O, Leufkens H, van Staa T. de Vries F, et al. Br J Clin Pharmacol. 2008 Apr;65(4):580-6. doi: 10.1111/j.1365-2125.2007.03077.x. Epub 2008 Feb 12. Br J Clin Pharmacol. 2008. PMID: 18279472 Free PMC article.

10

Gap in publication of comparative information on new medicines.

van Luijn JC, Stolk P, Gribnau FW, Leufkens HG. van Luijn JC, et al. Br J Clin Pharmacol. 2008 May;65(5):716-22. doi: 10.1111/j.1365-2125.2007.03092.x. Epub 2008 Feb 21. Br J Clin Pharmacol. 2008. PMID: 18294324 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

542 results

Search Page

Filters